{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:09:15Z","timestamp":1785308955641,"version":"3.55.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01434-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:54:51Z","timestamp":1751363691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cerebrovascular and Peripheral Vascular Complications in Cancer Patients"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-018X","authenticated-orcid":false,"given":"Julien","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1434_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.016","volume":"22","author":"N Sanossian","year":"2013","unstructured":"Sanossian N, Djabiras C, Mack WJ, Ovbiagele B. Trends in cancer diagnoses among inpatients hospitalized with stroke. J Stroke Cerebrovasc Dis. 2013;22:1146\u201350.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02374.x","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [10]. J Thromb Haemost. 2007. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x.","journal-title":"J Thromb Haemost"},{"key":"1434_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","volume":"118","author":"A Falanga","year":"2017","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol. 2017;118:79\u201383.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1434_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5853\/jos.2019.02278","volume":"22","author":"OY Bang","year":"2020","unstructured":"Bang OY, Chung JW, Lee MJ, Seo WK, Kim GM, Ahn MJ. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020;22:1\u201310.","journal-title":"J Stroke"},{"key":"1434_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/cjn.2021.55","volume":"49","author":"B Rioux","year":"2022","unstructured":"Rioux B, Gioia LC, Keezer MR. Risk of Cancer following an ischemic stroke in the Canadian longitudinal study on aging. Can J Neurol Sci. 2022;49:225\u201330.","journal-title":"Can J Neurol Sci"},{"key":"1434_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.5002","author":"JI Verhoeven","year":"2023","unstructured":"Verhoeven JI, Fan B, Broeders MJM, Driessen CML, Vaartjes ICH, Klijn CJM, De Leeuw FE. Association of stroke at young age with newcancer in the years after stroke among patients in the Netherlands. JAMA Netw Open. 2023. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5002.","journal-title":"JAMA Netw Open"},{"key":"1434_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00579","author":"YC Wei","year":"2019","unstructured":"Wei YC, Chen KF, Wu CL, Lee TW, Liu CH, Shyu YC, Lin CP. Stroke rate increases around the time of cancer diagnosis. Front Neurol. 2019. https:\/\/doi.org\/10.3389\/fneur.2019.00579.","journal-title":"Front Neurol"},{"key":"1434_CR8","doi-asserted-by":"crossref","unstructured":"Lin J, Wu S, Xu R, Shi Q, Tian C, Cui F, Shao X, Liu H. (2019) Clinical characteristics and risk factors of lung cancer-associated acute ischemic stroke.","DOI":"10.1155\/2019\/6021037"},{"key":"1434_CR9","doi-asserted-by":"publisher","first-page":"E2025","DOI":"10.1212\/WNL.0000000000005636","volume":"90","author":"BB Navi","year":"2018","unstructured":"Navi BB, Howard G, Howard VJ, et al. New diagnosis of cancer and the risk of subsequent cerebrovascular events. Neurology. 2018;90:E2025\u201333.","journal-title":"Neurology"},{"key":"1434_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.12.029","author":"DM Siegal","year":"2025","unstructured":"Siegal DM, Cerasuolo JO, Carrier M, Gross PL, Kapral MK, Kirkwood D, Lun R, Shamy M, Sutradhar R. Risk of ischemic stroke after cancer diagnosis: a population-based matched cohort study. J Thromb Haemost. 2025. https:\/\/doi.org\/10.1016\/j.jtha.2024.12.029.","journal-title":"J Thromb Haemost"},{"key":"1434_CR11","doi-asserted-by":"crossref","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, Panageas KS, Deangelis LM. (2019) Arterial thromboembolic events preceding the diagnosis of cancer in older persons.","DOI":"10.1182\/blood-2018-06-860874"},{"key":"1434_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1268131","author":"M Beyeler","year":"2023","unstructured":"Beyeler M, Castigliego P, Baumann J, et al. Transient ischemic attacks in patients with active and occult cancer. Front Neurol. 2023. https:\/\/doi.org\/10.3389\/fneur.2023.1268131.","journal-title":"Front Neurol"},{"key":"1434_CR13","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1212\/WNL.0000000000011264","volume":"96","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang K, Du P, Yang W, He Y, Li T, Mei Z. Risk of stroke in Cancer survivors: A Meta-analysis of Population-Based cohort studies. Neurology. 2021;96:E513\u201326.","journal-title":"Neurology"},{"key":"1434_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2233-1","author":"M Kato","year":"2016","unstructured":"Kato M, Shukuya T, Mori K, et al. Cerebral infarction in advanced non-small cell lung cancer: A case control study. BMC Cancer. 2016. https:\/\/doi.org\/10.1186\/s12885-016-2233-1.","journal-title":"BMC Cancer"},{"key":"1434_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00052","author":"HS Jang","year":"2019","unstructured":"Jang HS, Choi J, Shin J, Chung JW, Bang OY, Kim GM, Seo WK, Lee J. The long-term effect of cancer on incident stroke: A nationwide population-based cohort study in Korea. Front Neurol. 2019. https:\/\/doi.org\/10.3389\/fneur.2019.00052.","journal-title":"Front Neurol"},{"key":"1434_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1245\/s10434-023-14688-6","volume":"31","author":"J Rautiola","year":"2024","unstructured":"Rautiola J, Bj\u00f6rklund J, Zelic R, et al. Risk of postoperative ischemic stroke and myocardial infarction in patients operated for Cancer. Ann Surg Oncol. 2024;31:1739\u201348.","journal-title":"Ann Surg Oncol"},{"key":"1434_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.thromres.2018.03.011","volume":"165","author":"S Grazioli","year":"2018","unstructured":"Grazioli S, Paciaroni M, Agnelli G, et al. Cancer-associated ischemic stroke: A retrospective multicentre cohort study. Thromb Res. 2018;165:33\u20137.","journal-title":"Thromb Res"},{"key":"1434_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/acn3.291","volume":"3","author":"Y Gon","year":"2016","unstructured":"Gon Y, Okazaki S, Terasaki Y, Sasaki T, Yoshimine T, Sakaguchi M, Mochizuki H. Characteristics of cryptogenic stroke in cancer patients. Ann Clin Transl Neurol. 2016;3:280\u20137.","journal-title":"Ann Clin Transl Neurol"},{"key":"1434_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5853\/jos.2014.16.2.91","volume":"16","author":"K Kim","year":"2014","unstructured":"Kim K, Lee J-H. Risk factors and biomarkers of ischemic stroke in Cancer patients. J Stroke. 2014;16:91.","journal-title":"J Stroke"},{"key":"1434_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105299","author":"M Abdelsalam","year":"2020","unstructured":"Abdelsalam M, Abu-Hegazy M, El-Hadaad HA, Wahba H, Egila H, Esmael A. Pathophysiology, mechanism, and outcome of ischemic stroke in Cancer patients. J Stroke Cerebrovasc Dis. 2020. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105299.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ijc.33218","volume":"148","author":"RC Reulen","year":"2021","unstructured":"Reulen RC, Guha J, Bright CJ, et al. Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study. Int J Cancer. 2021;148:572\u201383.","journal-title":"Int J Cancer"},{"key":"1434_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2738","author":"YJ Chen","year":"2022","unstructured":"Chen YJ, Dong RG, Zhang MM, Sheng C, Guo PF, Sun J. Cancer-related stroke: exploring personalized therapy strategies. Brain Behav. 2022. https:\/\/doi.org\/10.1002\/brb3.2738.","journal-title":"Brain Behav"},{"key":"1434_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012858","author":"G Ntaios","year":"2019","unstructured":"Ntaios G, Perlepe K, Lambrou D, et al. Prevalence and overlap of potential embolic sources in patients with embolic stroke of undetermined source. J Am Heart Assoc. 2019. https:\/\/doi.org\/10.1161\/JAHA.119.012858.","journal-title":"J Am Heart Assoc"},{"key":"1434_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.thromres.2016.01.027","volume":"139","author":"F Abu Saadeh","year":"2016","unstructured":"Abu Saadeh F, Langhe R, Galvin DM, O Toole SA, O\u2019Donnell DM, Gleeson N, Norris LA. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy. Thromb Res. 2016;139:135\u201341.","journal-title":"Thromb Res"},{"key":"1434_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.006","volume":"24","author":"D Cocho","year":"2015","unstructured":"Cocho D, Gendre J, Boltes A, Espinosa J, Ricciardi AC, Pons J, Jimenez M, Otermin P. Predictors of occult cancer in acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 2015;24:1324\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238585","author":"MJ Patel","year":"2020","unstructured":"Patel MJ, Elzweig J. Non-bacterial thrombotic endocarditis: A rare presentation and literature review. BMJ Case Rep. 2020. https:\/\/doi.org\/10.1136\/bcr-2020-238585.","journal-title":"BMJ Case Rep"},{"key":"1434_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1136\/jnnp.2006.092940","volume":"77","author":"Y Iguchi","year":"2006","unstructured":"Iguchi Y, Kimura K, Kobayashi K, Ueno Y, Inoue T. Ischaemic stroke with malignancy May often be caused by Paradoxical embolism. J Neurol Neurosurg Psychiatry. 2006;77:1336\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1434_CR28","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2169\/internalmedicine.6201-20","volume":"60","author":"K Nakanishi","year":"2021","unstructured":"Nakanishi K, Kawano H, Yamagishi Y, Kamma H, Shiokawa Y, Hirano T. Tumor cells detected in retrieved thrombus: Cancer-associated stroke. Intern Med. 2021;60:2491\u20134.","journal-title":"Intern Med"},{"key":"1434_CR29","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1161\/STROKEAHA.120.032069","volume":"51","author":"CH Fu","year":"2020","unstructured":"Fu CH, Chen CH, Lin YH, Lee CW, Tsai LK, Tang SC, Shun CT, Jeng JS. Fibrin and Platelet-Rich composition in retrieved thrombi hallmarks stroke with active Cancer. Stroke. 2020;51:3723\u20137.","journal-title":"Stroke"},{"key":"1434_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5797\/jnet.oa.2023-0067","volume":"18","author":"S Magami","year":"2024","unstructured":"Magami S, Yoshida K, Nakao Y, Oishi H, Yamamoto T. A Single-Center experience of mechanical thrombectomy for Cancer-Associated ischemic stroke. J Neuroendovascular Therapy. 2024;18:37\u201346.","journal-title":"J Neuroendovascular Therapy"},{"key":"1434_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70037","author":"M Woock","year":"2025","unstructured":"Woock M, Rossi R, Jabrah D, et al. Clot signature in patients with large vessel occlusion stroke and concomitant active cancer. Eur J Neurol. 2025. https:\/\/doi.org\/10.1111\/ene.70037.","journal-title":"Eur J Neurol"},{"key":"1434_CR32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s11912-022-01280-6","volume":"24","author":"E Komlodi-Pasztor","year":"2022","unstructured":"Komlodi-Pasztor E, Gilbert MR, Armstrong TS. Diagnosis and management of stroke in adults with primary brain tumor. Curr Oncol Rep. 2022;24:1251\u20139.","journal-title":"Curr Oncol Rep"},{"key":"1434_CR33","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1161\/STROKEAHA.119.026373","volume":"50","author":"OY Bang","year":"2019","unstructured":"Bang OY, Chung JW, Cho YH, Oh MJ, Seo WK, Kim GM, Ahn MJ. Circulating dnas, a marker of neutrophil extracellular traposis and cancer-related stroke the Oasis-cancer study. Stroke. 2019;50:2944\u20137.","journal-title":"Stroke"},{"key":"1434_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaccao.2023.01.009","volume":"5","author":"S Feldman","year":"2023","unstructured":"Feldman S, Gupta D, Navi BB, Grace Ho KW, Willeit P, Devlin S, Bolton KL, Arcila ME, Mantha S. Tumor genomic profile is associated with arterial thromboembolism risk in patients with solid Cancer. JACC CardioOncol. 2023;5:246\u201355.","journal-title":"JACC CardioOncol"},{"key":"1434_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00415-015-7954-6","volume":"263","author":"M Kneihsl","year":"2016","unstructured":"Kneihsl M, Enzinger C, W\u00fcnsch G, Khalil M, Culea V, Urbanic-Purkart T, Payer F, Niederkorn K, Fazekas F, Gattringer T. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263:150\u20136.","journal-title":"J Neurol"},{"key":"1434_CR36","unstructured":"Chen Y, Zeng J, Xie X, Wang Z, Wang X, Liang Z. (2015) Clinical features of systemic cancer patients with acute cerebral infarction and its underlying pathogenesis."},{"key":"1434_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11739-021-02862-1","volume":"17","author":"T Nezu","year":"2022","unstructured":"Nezu T, Hosomi N, Naito H, et al. Clinical characteristics and tumor markers in ischemic stroke patients with active cancer. Intern Emerg Med. 2022;17:735\u201341.","journal-title":"Intern Emerg Med"},{"key":"1434_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5853\/jos.2022.02334","volume":"25","author":"H Aboul-Nour","year":"2023","unstructured":"Aboul-Nour H, Maraey A, Jumah A, Khalil M, Elzanaty AM, Elsharnoby H, Al-Mufti F, Chebl AB, Miller DJ, Mayer SA. Mechanical thrombectomy for acute ischemic stroke in metastatic Cancer patients: A nationwide Cross-Sectional analysis. J Stroke. 2023;25:119\u201325.","journal-title":"J Stroke"},{"key":"1434_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00811","author":"HA Selvik","year":"2018","unstructured":"Selvik HA, Naess H, Kvistad CE. Intravenous thrombolysis in ischemic stroke patients with active Cancer. Front Neurol. 2018. https:\/\/doi.org\/10.3389\/fneur.2018.00811.","journal-title":"Front Neurol"},{"key":"1434_CR40","doi-asserted-by":"crossref","unstructured":"Huang S, Lu X, Tang LV, Hu Y. (2020) Efficacy and safety of intravenous thrombolysis for acute ischemic stroke in cancer patients: a systemic review and meta-analysis.","DOI":"10.21203\/rs.3.rs-22752\/v1"},{"key":"1434_CR41","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s11739-023-03312-w","volume":"18","author":"MG Mosconi","year":"2023","unstructured":"Mosconi MG, Capponi A, Paciaroni M. Systemic thrombolysis in patients with acute stroke and active cancer: a systematic review and meta-analysis. Intern Emerg Med. 2023;18:1843\u201350.","journal-title":"Intern Emerg Med"},{"key":"1434_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107294","author":"S Rael","year":"2023","unstructured":"Rael S, Webb M, Brown RD, Ruff MW, Keser Z, Sener U. Safety of intravenous thrombolysis for ischemic stroke in patients with hematologic malignancies: A single institution experience. J Stroke Cerebrovasc Dis. 2023. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107294.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR43","doi-asserted-by":"publisher","first-page":"E344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American heart association\/american stroke association. Stroke. 2019;50:E344\u2013418.","journal-title":"Stroke"},{"key":"1434_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.004","volume":"23","author":"T Etgen","year":"2014","unstructured":"Etgen T, Steinich I, Gsottschneider L. Thrombolysis for ischemic stroke in patients with brain tumors. J Stroke Cerebrovasc Dis. 2014;23:361\u20136.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR45","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jocn.2014.09.016","volume":"22","author":"SB Murthy","year":"2015","unstructured":"Murthy SB, Moradiya Y, Shah S, Shastri A, Bershad EM, Suarez JI. In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumors. J Clin Neurosci. 2015;22:474\u20138.","journal-title":"J Clin Neurosci"},{"key":"1434_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/503758","author":"W Neil","year":"2011","unstructured":"Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Rep Med. 2011. https:\/\/doi.org\/10.1155\/2011\/503758.","journal-title":"Case Rep Med"},{"key":"1434_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617753423","author":"CJ Schwarzbach","year":"2018","unstructured":"Schwarzbach CJ, Ebert A, Hennerici MG, Neumaier-Probst E, Platten M, Fatar M. Off-label use of IV t-PA in patients with intracranial neoplasm and Cavernoma. Ther Adv Neurol Disord. 2018. https:\/\/doi.org\/10.1177\/1756285617753423.","journal-title":"Ther Adv Neurol Disord"},{"key":"1434_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/23969873221100897","volume":"7","author":"D Caimano","year":"2022","unstructured":"Caimano D, Letteri F, Capasso F, et al. Endovascular treatment in patients with acute ischemic stroke and cancer: systematic review and meta-analysis. Eur Stroke J. 2022;7:204\u201311.","journal-title":"Eur Stroke J"},{"key":"1434_CR49","unstructured":"Tang Y, Cruz Culebras A, Ali M, Yang B. Outcomes after endovascular thrombectomy for acute ischemic stroke patients with active cancer: A systematic review and meta-analysis."},{"key":"1434_CR50","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200320","author":"MN Elmarawany","year":"2024","unstructured":"Elmarawany MN, El Malky I, Winklhofer S, Katan M, Kar S, Baltsavias G. Outcomes of mechanical thrombectomy for acute ischemic stroke in Cancer patients: A Single-Center experience and Meta-Analysis. Neurol Clin Pract. 2024. https:\/\/doi.org\/10.1212\/CPJ.0000000000200320.","journal-title":"Neurol Clin Pract"},{"key":"1434_CR51","doi-asserted-by":"publisher","first-page":"E154","DOI":"10.1136\/jnis-2022-019489","volume":"15","author":"HJ Jhou","year":"2023","unstructured":"Jhou HJ, Yang LY, Chen PH, Lee CH. Endovascular therapy for acute ischemic stroke in patients with active malignancy: a meta-analysis with trial sequential analysis. J Neurointerv Surg. 2023;15:E154\u201360.","journal-title":"J Neurointerv Surg"},{"key":"1434_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10072-019-04103-y","volume":"41","author":"BH Cho","year":"2020","unstructured":"Cho BH, Yoon W, Kim JT, Choi KH, Kang KW, Lee JH, Cho KH, Park MS. Outcomes of endovascular treatment in acute ischemic stroke patients with current malignancy. Neurol Sci. 2020;41:379\u201385.","journal-title":"Neurol Sci"},{"key":"1434_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/15910199241230356","author":"M Toruno","year":"2024","unstructured":"Toruno M, Al-Janabi O, Karaman I, Ghozy S, Senol YC, Kobeissi H, Kadirvel R, Ashdown B, Kallmes DF. Mechanical thrombectomy for the treatment of large vessel occlusion due to cancer-related cerebral embolism: A systematic review. Interventional Neuroradiol. 2024. https:\/\/doi.org\/10.1177\/15910199241230356.","journal-title":"Interventional Neuroradiol"},{"key":"1434_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02086-y","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Bae J, Jeong HB, Lee EJ, Jeong HY, Yoon BW. Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome. BMC Neurol. 2021. https:\/\/doi.org\/10.1186\/s12883-021-02086-y.","journal-title":"BMC Neurol"},{"key":"1434_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/502089","author":"H Jang","year":"2015","unstructured":"Jang H, Lee JJ, Lee MJ, Ryoo S, Yoon CH, Kim GM, Chung CS, Lee KH, Bang OY, Kim SJ. Comparison of Enoxaparin and warfarin for secondary prevention of Cancer-Associated stroke. J Oncol. 2015. https:\/\/doi.org\/10.1155\/2015\/502089.","journal-title":"J Oncol"},{"key":"1434_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.10.012","volume":"28","author":"H Kawano","year":"2019","unstructured":"Kawano H, Honda Y, Amano T, Okano H, Suzuki R, Torii M, Unno Y, Shiokawa Y, Hirano T. Subcutaneous heparin therapy for patients with Cancer-Associated stroke. J Stroke Cerebrovasc Dis. 2019;28:399\u2013404.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/ene.14172","volume":"27","author":"N Martinez-Majander","year":"2020","unstructured":"Martinez-Majander N, Ntaios G, Liu YY, et al. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial. Eur J Neurol. 2020;27:841\u20138.","journal-title":"Eur J Neurol"},{"key":"1434_CR58","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamaneurol.2024.2404","volume":"81","author":"BB Navi","year":"2024","unstructured":"Navi BB, Zhang C, Miller B, et al. Apixaban vs aspirin in patients with Cancer and cryptogenic stroke: A post hoc analysis of the ARCADIA randomized clinical trial. JAMA Neurol. 2024;81:958\u201365.","journal-title":"JAMA Neurol"},{"key":"1434_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.thromres.2021.08.016","volume":"206","author":"G Yamaura","year":"2021","unstructured":"Yamaura G, Ito T, Miyaji Y, et al. Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism. Thromb Res. 2021;206:99\u2013103.","journal-title":"Thromb Res"},{"key":"1434_CR60","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.029","volume":"26","author":"KW Nam","year":"2017","unstructured":"Nam KW, Kim CK, Kim TJ, An SJ, Oh K, Ko SB, Yoon BW. Treatment of cryptogenic stroke with active Cancer with a new oral anticoagulant. J Stroke Cerebrovasc Dis. 2017;26:2976\u201380.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010123","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Chung JW, Bang OY, Cho YH, Lim YJ, Hwang J, Seo WK, Kim GM, Kim HJ, Ahn MJ. The role of factor xa-independent pathway and anticoagulant therapies in cancer-related stroke. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11010123.","journal-title":"J Clin Med"},{"key":"1434_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5853\/jos.2016.00570","volume":"19","author":"MJ Lee","year":"2017","unstructured":"Lee MJ, Chung JW, Ahn MJ, Kim S, Seok JM, Jang HM, Kim GM, Chung CS, Lee KH, Bang OY. Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study. J Stroke. 2017;19:77\u201387.","journal-title":"J Stroke"},{"key":"1434_CR63","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaneurol.2017.4211","volume":"75","author":"BB Navi","year":"2018","unstructured":"Navi BB, Marshall RS, Bobrow D, Singer S, Stone JB, DeSancho MT, DeAngelis LM. Enoxaparin vs aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial. JAMA Neurol. 2018;75:379\u201381.","journal-title":"JAMA Neurol"},{"key":"1434_CR64","doi-asserted-by":"publisher","unstructured":"Boulet J, Pe ~ J, Hulten EA et al. Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck. https:\/\/doi.org\/10.1161\/JAHA","DOI":"10.1161\/JAHA"},{"key":"1434_CR65","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1161\/STROKEAHA.122.038829","volume":"53","author":"MT Olaiya","year":"2022","unstructured":"Olaiya MT, Andrew NE, Dalli LL, et al. Does a history of cancer influence the effectiveness of Statins on outcomes after stroke? Stroke. 2022;53:3202\u20135.","journal-title":"Stroke? Stroke"},{"key":"1434_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2174\/1389450120666181211165449","volume":"20","author":"M Gachpazan","year":"2018","unstructured":"Gachpazan M, Kashani H, Khazaei M, Hassanian SM, Rezayi M, Asgharzadeh F, Ghayour-Mobarhan M, Ferns GA, Avan A. The impact of Statin therapy on the survival of patients with Gastrointestinal Cancer. Curr Drug Targets. 2018;20:738\u201347.","journal-title":"Curr Drug Targets"},{"key":"1434_CR67","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","volume":"52","author":"BB Navi","year":"2021","unstructured":"Navi BB, Kasner SE, Elkind MSV, Cushman M, Bang OY, Deangelis LM. Cancer and embolic stroke of undetermined source. Stroke. 2021;52:1121\u201330.","journal-title":"Stroke"},{"key":"1434_CR68","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/cncr.35361","volume":"130","author":"W Jung","year":"2024","unstructured":"Jung W, Cho IY, Jung J, et al. Association between physical activity changes and risk of incident ischemic stroke following cancer diagnosis: A nationwide retrospective cohort study. Cancer. 2024;130:2873\u201385.","journal-title":"Cancer"},{"key":"1434_CR69","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00415-017-8432-0","volume":"264","author":"R Kassubek","year":"2017","unstructured":"Kassubek R, Bullinger L, Kassubek J, Dreyhaupt J, Ludolph AC, Althaus K, Lewerenz J. Identifying ischemic stroke associated with cancer: a multiple model derived from a case\u2013control analysis. J Neurol. 2017;264:781\u201391.","journal-title":"J Neurol"},{"key":"1434_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16200","author":"G Costamagna","year":"2024","unstructured":"Costamagna G, Hottinger AF, Milionis H, Salerno A, Strambo D, Livio F, Navi BB, Michel P. Acute ischaemic stroke in active cancer versus non-cancer patients: stroke characteristics, mechanisms and clinical outcomes. Eur J Neurol. 2024. https:\/\/doi.org\/10.1111\/ene.16200.","journal-title":"Eur J Neurol"},{"key":"1434_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2023.100474","author":"KP Lee","year":"2023","unstructured":"Lee KP, Huang HC, Tsai JY, Hsu LC. Effects of cancer on stroke recurrence and mortality: A single-center retrospective cohort study. eNeurologicalSci. 2023. https:\/\/doi.org\/10.1016\/j.ensci.2023.100474.","journal-title":"eNeurologicalSci"},{"key":"1434_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092193","author":"TA Pana","year":"2021","unstructured":"Pana TA, Mohamed MO, Mamas MA, Myint PK. Prognosis of acute ischaemic stroke patients with cancer: A National inpatient sample study. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13092193.","journal-title":"Cancers (Basel)"},{"key":"1434_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03690-4","author":"Q Wang","year":"2024","unstructured":"Wang Q, Fu W, Wang F. Malignant tumor increases the risk of all causes in-hospital mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. BMC Neurol. 2024. https:\/\/doi.org\/10.1186\/s12883-024-03690-4.","journal-title":"BMC Neurol"},{"key":"1434_CR74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.thromres.2023.01.005","volume":"222","author":"Y Gon","year":"2023","unstructured":"Gon Y, Zha L, Sasaki T, Morishima T, Ohno Y, Mochizuki H, Sobue T, Miyashiro I. Stroke mortality in cancer survivors: A population-based study in Japan. Thromb Res. 2023;222:140\u20138.","journal-title":"Thromb Res"},{"key":"1434_CR75","doi-asserted-by":"crossref","unstructured":"Navi BB, Singer S, Merkler AE, Cheng NT, Stone JB, Kamel H, Iadecola C, Elkind MSV, Deangelis LM. (2014) Recurrent thromboembolic events after ischemic stroke in patients with cancer.","DOI":"10.1212\/WNL.0000000000000539"},{"key":"1434_CR76","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-012-1011-4","volume":"111","author":"JM Kim","year":"2013","unstructured":"Kim JM, Jung KH, Park KH, Lee ST, Chu K, Roh JK. Clinical manifestation of cancer related stroke: retrospective case-control study. J Neurooncol. 2013;111:295\u2013301.","journal-title":"J Neurooncol"},{"key":"1434_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000491436","volume":"46","author":"J Fujinami","year":"2018","unstructured":"Fujinami J, Ohara T, Kitani-Morii F, Tomii Y, Makita N, Yamada T, Kasai T, Nagakane Y, Nakagawa M, Mizuno T. Cancer-Associated hypercoagulation increases the risk of early recurrent stroke in patients with active Cancer. Cerebrovasc Dis. 2018;46:46\u201351.","journal-title":"Cerebrovasc Dis"},{"key":"1434_CR78","doi-asserted-by":"publisher","DOI":"10.1159\/000535644","author":"J Fujinami","year":"2023","unstructured":"Fujinami J, Nagakane Y, Fujikawa K, Murata S, Maezono K, Ohara T, Mizuno T. D-Dimer trends predict recurrent stroke in patients with Cancer-Related hypercoagulability. Cerebrovasc Dis Extra. 2023. https:\/\/doi.org\/10.1159\/000535644.","journal-title":"Cerebrovasc Dis Extra"},{"key":"1434_CR79","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/jth.15779","volume":"20","author":"BB Navi","year":"2022","unstructured":"Navi BB, Zhang C, Sherman CP, et al. Ischemic stroke with cancer: hematologic and embolic biomarkers and clinical outcomes. J Thromb Haemost. 2022;20:2046\u201357.","journal-title":"J Thromb Haemost"},{"key":"1434_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/ene.13184","volume":"24","author":"KW Nam","year":"2017","unstructured":"Nam KW, Kim CK, Kim TJ, An SJ, Demchuk AM, Kim Y, Jung S, Han MK, Ko SB, Yoon BW. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer. Eur J Neurol. 2017;24:205\u201311.","journal-title":"Eur J Neurol"},{"key":"1434_CR81","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029618","author":"Y Gon","year":"2023","unstructured":"Gon Y, Sakaguchi M, Yamagami H, et al. Predictors of survival in patients with ischemic stroke and active cancer: A prospective, multicenter, observational study. J Am Heart Assoc. 2023. https:\/\/doi.org\/10.1161\/JAHA.123.029618.","journal-title":"J Am Heart Assoc"},{"key":"1434_CR82","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032284","author":"T Kawano","year":"2024","unstructured":"Kawano T, Gon Y, Sakaguchi M, et al. Von Willebrand factor antigen levels predict poor outcomes in patients with stroke and cancer: findings from the multicenter, prospective, observational SCAN study. J Am Heart Assoc. 2024. https:\/\/doi.org\/10.1161\/JAHA.123.032284.","journal-title":"J Am Heart Assoc"},{"key":"1434_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259627","author":"KW Nam","year":"2021","unstructured":"Nam KW, Kwon HM, Lee YS. Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0259627.","journal-title":"PLoS ONE"},{"key":"1434_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97154-1","author":"KW Nam","year":"2021","unstructured":"Nam KW, Kwon HM, Lee YS, Kim JM, Ko SB. Effects of cerebral small vessel disease on the outcomes in cryptogenic stroke with active cancer. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-97154-1.","journal-title":"Sci Rep"},{"key":"1434_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120246","author":"T Nezu","year":"2022","unstructured":"Nezu T, Hosomi N, Aoki S, et al. Short-term or long-term outcomes for stroke patients with cancer according to biological markers. J Neurol Sci. 2022. https:\/\/doi.org\/10.1016\/j.jns.2022.120246.","journal-title":"J Neurol Sci"},{"key":"1434_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.843871","author":"KH Pan","year":"2022","unstructured":"Pan KH, Kim J, Chung JW, Kim KH, Bang OY, Jeon P, Kim GM, Seo WK. Significance of D-Dimer in acute ischemic stroke patients with large vessel occlusion accompanied by active Cancer. Front Neurol. 2022. https:\/\/doi.org\/10.3389\/fneur.2022.843871.","journal-title":"Front Neurol"},{"key":"1434_CR87","doi-asserted-by":"publisher","DOI":"10.1177\/23969873241263402","author":"F Wahbeh","year":"2024","unstructured":"Wahbeh F, Zhang C, Beyeler M, Kaiser JH, Liao V, Pawar A, Kamel H, Navi BB. Atrial fibrillation and short-term outcomes after cancer-related ischemic stroke. Eur Stroke J. 2024. https:\/\/doi.org\/10.1177\/23969873241263402.","journal-title":"Eur Stroke J"},{"key":"1434_CR88","doi-asserted-by":"publisher","unstructured":"Naftali J, Barnea R, Leader A et al. (2024) Association of acute incidental cerebral microinfarcts with subsequent ischemic stroke in patients with cancer. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000209655","DOI":"10.1212\/WNL.0000000000209655"},{"key":"1434_CR89","doi-asserted-by":"crossref","unstructured":"Tieck MP, Single C, Poli S, Kowarik MC, Ziemann U, Mengel A, Feil K. (2025) Screening tools for malignancy in patients with cryptogenic stroke: systematic review. Eur Stroke J 23969873241310760.","DOI":"10.1177\/23969873241310760"},{"key":"1434_CR90","doi-asserted-by":"publisher","unstructured":"Payne AB, Adamski A, Abe K, Reyes NL, Richardson LC, Hooper WC, Schieve LA. (2022) Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the united states, 2018 and 2019. Res Pract Thromb Haemost. https:\/\/doi.org\/10.1002\/rth2.12682","DOI":"10.1002\/rth2.12682"},{"key":"1434_CR91","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s11239-024-02997-w","volume":"57","author":"MC Vedovati","year":"2024","unstructured":"Vedovati MC, Shu L, Henninger N, et al. Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study. J Thromb Thrombolysis. 2024;57:1008\u201317.","journal-title":"J Thromb Thrombolysis"},{"key":"1434_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01059.x","volume":"119","author":"W Grisold","year":"2009","unstructured":"Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: A review. Acta Neurol Scand. 2009;119:1\u201316.","journal-title":"Acta Neurol Scand"},{"key":"1434_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8610903","author":"D Uluduz","year":"2020","unstructured":"Uluduz D, Sahin S, Duman T, et al. Cerebral venous sinus thrombosis in women: subgroup analysis of the VENOST study. Stroke Res Treat. 2020. https:\/\/doi.org\/10.1155\/2020\/8610903.","journal-title":"Stroke Res Treat"},{"key":"1434_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316849","author":"P Sitthilok","year":"2025","unstructured":"Sitthilok P, Niprapan P, Tantiworawit A, et al. Clinical course and neurological outcomes of cerebral venous sinus thrombosis: A single center retrospective observational study. PLoS ONE. 2025. https:\/\/doi.org\/10.1371\/journal.pone.0316849.","journal-title":"PLoS ONE"},{"key":"1434_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26694","author":"KM Ghanem","year":"2017","unstructured":"Ghanem KM, Dhayni RM, Al-Aridi C, Tarek N, Tamim H, Chan AKC, Saab R, Abboud MR, El-Solh H, Muwakkit SA. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: risk factors and management. Pediatr Blood Cancer. 2017. https:\/\/doi.org\/10.1002\/pbc.26694.","journal-title":"Pediatr Blood Cancer"},{"key":"1434_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29210","author":"H El-Khoury","year":"2021","unstructured":"El-Khoury H, Saifi O, Haddad S, et al. Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: new risk factors to consider. Pediatr Blood Cancer. 2021. https:\/\/doi.org\/10.1002\/pbc.29210.","journal-title":"Pediatr Blood Cancer"},{"key":"1434_CR97","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/STROKEAHA.114.007584","volume":"46","author":"JM Coutinho","year":"2015","unstructured":"Coutinho JM, Stam J, Canh\u00e3o P, Barinagarrementeria F, Bousser MG, Ferro JM. Cerebral venous thrombosis in the absence of headache. Stroke. 2015;46:245\u20137.","journal-title":"Stroke"},{"key":"1434_CR98","doi-asserted-by":"publisher","first-page":"E77","DOI":"10.1161\/STR.0000000000000456","volume":"55","author":"G Saposnik","year":"2024","unstructured":"Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and management of cerebral venous thrombosis: A scientific statement from the American heart association. Stroke. 2024;55:E77\u201390.","journal-title":"Stroke"},{"key":"1434_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04059-x","author":"L Lin","year":"2025","unstructured":"Lin L, Liu S, Wang W, He XK, Romli MH, Rajen Durai R. Key prognostic risk factors linked to poor functional outcomes in cerebral venous sinus thrombosis: a systematic review and meta-analysis. BMC Neurol. 2025. https:\/\/doi.org\/10.1186\/s12883-025-04059-x.","journal-title":"BMC Neurol"},{"key":"1434_CR100","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11912-021-01178-9","volume":"24","author":"M Diaz","year":"2022","unstructured":"Diaz M, Jo J. Venous thrombotic events and anticoagulation in brain tumor patients. Curr Oncol Rep. 2022;24:493\u2013500.","journal-title":"Curr Oncol Rep"},{"key":"1434_CR101","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/neuonc\/noad059","volume":"25","author":"J Jo","year":"2023","unstructured":"Jo J, Diaz M, Horbinski C, et al. Epidemiology, biology, and management of venous thromboembolism in gliomas: an interdisciplinary review. Neuro Oncol. 2023;25:1381\u201394.","journal-title":"Neuro Oncol"},{"key":"1434_CR102","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.thromres.2015.11.027","volume":"137","author":"NC Edwin","year":"2016","unstructured":"Edwin NC, Khoury MN, Sohal D, McCrae KR, Ahluwalia MS, Khorana AA. Recurrent venous thromboembolism in glioblastoma. Thromb Res. 2016;137:184\u20138.","journal-title":"Thromb Res"},{"key":"1434_CR103","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/ene.15404","volume":"29","author":"A Eisele","year":"2022","unstructured":"Eisele A, Seystahl K, Rushing EJ, Roth P, Le Rhun E, Weller M, Gramatzki D. Venous thromboembolic events in glioblastoma patients: an epidemiological study. Eur J Neurol. 2022;29:2386\u201397.","journal-title":"Eur J Neurol"},{"key":"1434_CR104","unstructured":"Bell Burdett K, Unruh D, Drumm M et al. Determining venous thromboembolism risk in patients with adult-type diffuse glioma."},{"key":"1434_CR105","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11060-015-1805-2","volume":"124","author":"S Yust-Katz","year":"2015","unstructured":"Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS. Venous thromboembolism (VTE) and glioblastoma. J Neurooncol. 2015;124:87\u201394.","journal-title":"J Neurooncol"},{"key":"1434_CR106","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-021-03791-x","volume":"154","author":"M Saito","year":"2021","unstructured":"Saito M, Wages NA, Schiff D. Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma. J Neurooncol. 2021;154:41\u20137.","journal-title":"J Neurooncol"},{"key":"1434_CR107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.thromres.2020.11.005","volume":"197","author":"S Lopez-Ruz","year":"2021","unstructured":"Lopez-Ruz S, Barca-Hernando M, Jara-Palomares L. Deep vein thrombosis and brain metastases. Case report and systematic review. Thromb Res. 2021;197:195\u2013201.","journal-title":"Thromb Res"},{"key":"1434_CR108","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s11239-017-1536-7","volume":"44","author":"BD Hunter","year":"2017","unstructured":"Hunter BD, Minichiello T, Bent S. Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review. J Thromb Thrombolysis. 2017;44:392\u20138.","journal-title":"J Thromb Thrombolysis"},{"key":"1434_CR109","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11060-016-2259-x","volume":"130","author":"N Alshehri","year":"2016","unstructured":"Alshehri N, Cote DJ. Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol. 2016;130:561\u201370.","journal-title":"J Neurooncol"},{"key":"1434_CR110","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/j.1538-7836.2010.03973.x","volume":"8","author":"JR Perry","year":"2010","unstructured":"Perry JR, Julian JA, Laperriere NJ, et al. PRODIGE: A randomized placebo-controlled trial of Dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost. 2010;8:1959\u201365.","journal-title":"J Thromb Haemost"},{"key":"1434_CR111","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11239-021-02537-w","volume":"53","author":"AA Thomas","year":"2022","unstructured":"Thomas AA, Wright H, Chan K, Ross H, Prasad P, Goodwin A, Holmes CE. Safety of Apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma. J Thromb Thrombolysis. 2022;53:479\u201384.","journal-title":"J Thromb Thrombolysis"},{"key":"1434_CR112","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1007\/s00520-022-07050-1","volume":"30","author":"Y Huang","year":"2022","unstructured":"Huang Y, Ding H, Luo M, Li S, Xie C, Zhong Y, Li Z. Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma. Support Care Cancer. 2022;30:6063\u20139.","journal-title":"Support Care Cancer"},{"key":"1434_CR113","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11239-016-1434-4","volume":"43","author":"CM Rojas-Hernandez","year":"2017","unstructured":"Rojas-Hernandez CM, Oo TH, Garc\u00eda-Perdomo HA. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis. J Thromb Thrombolysis. 2017;43:233\u201340.","journal-title":"J Thromb Thrombolysis"},{"key":"1434_CR114","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1182\/bloodadvances.2022008086","volume":"6","author":"M Giustozzi","year":"2022","unstructured":"Giustozzi M, Proietti G, Becattini C, Roila F, Agnelli G, Mandal\u00e0 M. ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis. Blood Adv. 2022;6:4873\u201383.","journal-title":"Blood Adv"},{"key":"1434_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67316-8","author":"V Lee","year":"2020","unstructured":"Lee V, Jairam V, Yu JB, Park HS. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-67316-8.","journal-title":"Sci Rep"},{"key":"1434_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04811-2","author":"S Eminovic","year":"2024","unstructured":"Eminovic S, Orth T, Dell\u2019Orco A, Baumg\u00e4rtner L, Morotti A, Wasilewski D, Guelen MS, Scheel M, Penzkofer T, Nawabi J. Clinical and imaging manifestations of intracerebral hemorrhage in brain tumors and metastatic lesions: a comprehensive overview. J Neurooncol. 2024. https:\/\/doi.org\/10.1007\/s11060-024-04811-2.","journal-title":"J Neurooncol"},{"key":"1434_CR117","doi-asserted-by":"crossref","unstructured":"Navi BB, Reichman JS, Berlin D, Reiner AS, Panageas MKS, Segal DAZ, Deangelis LM. (2010) Intracerebral and subarachnoid hemorrhage in patients with cancer.","DOI":"10.1212\/WNL.0b013e3181cef837"},{"key":"1434_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-97","author":"CY Chen","year":"2012","unstructured":"Chen CY, Tai CH, Cheng A, et al. Intracranial hemorrhage in adult patients with hematological malignancies. BMC Med. 2012. https:\/\/doi.org\/10.1186\/1741-7015-10-97.","journal-title":"BMC Med"},{"key":"1434_CR119","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1053\/adpa.2000.19368","volume":"4","author":"NA Abrahams","year":"2000","unstructured":"Abrahams NA, Prayson RA. The role of histopathologic examination of intracranial blood clots removed for hemorrhage of unknown etiology: A clinical pathologic analysis of 31 cases. Ann Diagn Pathol. 2000;4:361\u20136.","journal-title":"Ann Diagn Pathol"},{"key":"1434_CR120","doi-asserted-by":"crossref","unstructured":"Kothbauer P, Jellinger K, Flament H. (1979) ACTA NEUROCHIRURGICA Primary Brain Turnout Presenting as Spontaneous Intracerebral Haemorrhage*.","DOI":"10.1007\/BF01809172"},{"key":"1434_CR121","doi-asserted-by":"publisher","unstructured":"Schrader B, Barth H, Lang EW, et al. Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien). 2000;142(9):979\u2013985. https:\/\/doi.org\/10.1007\/s007010070052","DOI":"10.1007\/s007010070052"},{"key":"1434_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.617966","author":"M Zoccarato","year":"2021","unstructured":"Zoccarato M, Nardetto L, Basile AM, Giometto B, Zagonel V, Lombardi G. Seizures, edema, thrombosis, and hemorrhages: an update review on the medical management of gliomas. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.617966.","journal-title":"Front Oncol"},{"key":"1434_CR123","first-page":"E314","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: A guideline from the American heart association\/american stroke association. Stroke. 2023;54:E314\u201370.","journal-title":"Stroke"},{"key":"1434_CR124","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American heart association\/american stroke association. Stroke. 2022;53:E282\u2013361.","journal-title":"Stroke"},{"key":"1434_CR125","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-024-04714-2","volume":"169","author":"L Rauschenbach","year":"2024","unstructured":"Rauschenbach L, Kolbe P, Engel A, et al. Predictors and surgical outcome of hemorrhagic metastatic brain malignancies. J Neurooncol. 2024;169:165\u201373.","journal-title":"J Neurooncol"},{"key":"1434_CR126","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3171\/2023.7.JNS231225","volume":"140","author":"S Hong","year":"2024","unstructured":"Hong S, Bouchal SM, Bauman MMJ, et al. The longitudinal risk of hemorrhage of melanoma brain metastases after gamma knife radiosurgery. J Neurosurg. 2024;140:938\u201348.","journal-title":"J Neurosurg"},{"key":"1434_CR127","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-023-04404-5","volume":"164","author":"PA Jablonska","year":"2023","unstructured":"Jablonska PA, Muniz T, Ribeiro M, et al. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis. J Neurooncol. 2023;164:199\u2013209.","journal-title":"J Neurooncol"},{"key":"1434_CR128","doi-asserted-by":"publisher","unstructured":"Zoga E, Wolff R, Ackermann H, Meissner M, R\u00f6del C, Tselis N, Chatzikonstantinou G. (2022) Factors associated with hemorrhage of melanoma brain metastases after stereotactic radiosurgery in the era of targeted\/immune checkpoint inhibitor therapies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14102391","DOI":"10.3390\/cancers14102391"},{"key":"1434_CR129","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-018-2933-2","volume":"140","author":"K Bauer-Nilsen","year":"2018","unstructured":"Bauer-Nilsen K, Trifiletti DM, Chatrath A, Ruiz-Garcia H, Marchan E, Peterson J, May BC, Sheehan JP. Stereotactic radiosurgery for brain metastases from malignant melanoma and the impact of hemorrhagic metastases. J Neurooncol. 2018;140:83\u20138.","journal-title":"J Neurooncol"},{"key":"1434_CR130","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11060-022-04178-2","volume":"160","author":"G McKenzie","year":"2022","unstructured":"McKenzie G, Gaskins J, Rattani A, Oliver A, Southall W, Nakamura F, Yusuf M, Mistry A, Williams B, Woo S. Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases. J Neurooncol. 2022;160:591\u20139.","journal-title":"J Neurooncol"},{"key":"1434_CR131","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/ene.13456","volume":"25","author":"Y Gon","year":"2018","unstructured":"Gon Y, Todo K, Mochizuki H, Sakaguchi M. Cancer is an independent predictor of poor outcomes in patients following intracerebral hemorrhage. Eur J Neurol. 2018;25:128\u201334.","journal-title":"Eur J Neurol"},{"key":"1434_CR132","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.08.006","volume":"25","author":"SB Murthy","year":"2016","unstructured":"Murthy SB, Shastri A, Merkler AE, Hanley DF, Ziai WC, Fink ME, Iadecola C, Kamel H, Navi BB. Intracerebral hemorrhage outcomes in patients with systemic Cancer. J Stroke Cerebrovasc Dis. 2016;25:2918\u201324.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR133","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.wneu.2020.06.091","volume":"144","author":"A Raghavan","year":"2020","unstructured":"Raghavan A, Wright CH, Wright JM, Jensen K, Malloy P, Elder T, Burant C, Sajatovic M, Hoffer A. Outcomes and clinical characteristics of intracranial hemorrhage in patients with hematologic malignancies: A systematic literature review. World Neurosurg. 2020;144:e15\u201324.","journal-title":"World Neurosurg"},{"key":"1434_CR134","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jtha.2023.01.031","volume":"21","author":"S Ma","year":"2023","unstructured":"Ma S, Patell R, Miller E, et al. Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors. J Thromb Haemost. 2023;21:1148\u201355.","journal-title":"J Thromb Haemost"},{"key":"1434_CR135","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/bloodadvances.2021006470","volume":"6","author":"EJ Miller","year":"2022","unstructured":"Miller EJ, Patell R, Uhlmann EJ, Ren S, Southard H, Elavalakanar P, Weber GM, Neuberg D, Zwicker JI. Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors. Blood Adv. 2022;6:1559\u201365.","journal-title":"Blood Adv"},{"key":"1434_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1638","author":"A Porfidia","year":"2020","unstructured":"Porfidia A, Giordano M, Sturiale CL, D\u2019Arrigo S, Donadini MP, Olivi A, Ageno W, Pola R. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis. Brain Behav. 2020. https:\/\/doi.org\/10.1002\/brb3.1638.","journal-title":"Brain Behav"},{"key":"1434_CR137","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/jth.13387","volume":"14","author":"JI Zwicker","year":"2016","unstructured":"Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. J Thromb Haemost. 2016;14:1736\u201340.","journal-title":"J Thromb Haemost"},{"key":"1434_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107243","author":"J Yang","year":"2023","unstructured":"Yang J, He Z, Li M, Hong T, Ouyang T. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis. J Stroke Cerebrovasc Dis. 2023. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2023.107243.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR139","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jtha.2023.10.011","volume":"22","author":"V Iyengar","year":"2024","unstructured":"Iyengar V, Agrawal S, Chiasakul T, Tehranchi K, Mcnichol M, Carney BJ, Leader A, Zwicker JI, Patell R. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review. J Thromb Haemost. 2024;22:423\u20139.","journal-title":"J Thromb Haemost"},{"key":"1434_CR140","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-011-0642-1","volume":"106","author":"AD Norden","year":"2012","unstructured":"Norden AD, Bartolomeo J, Tanaka S, et al. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients. J Neurooncol. 2012;106:121\u20135.","journal-title":"J Neurooncol"},{"key":"1434_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.07.111","author":"D Bailey","year":"2024","unstructured":"Bailey D, Wilding H, Ganesalingam N, Rizk E. Perioperative management of antiplatelet and anticoagulation in brain tumor surgery: A survey of international practices. World Neurosurg. 2024. https:\/\/doi.org\/10.1016\/j.wneu.2024.07.111.","journal-title":"World Neurosurg"},{"key":"1434_CR142","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3171\/2018.12.JNS182483","volume":"132","author":"S Hanalioglu","year":"2020","unstructured":"Hanalioglu S, Sahin B, Sahin OS, Kozan A, Ucer M, Cikla U, Goodman SL, Baskaya MK. Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study. J Neurosurg. 2020;132:1529\u201338.","journal-title":"J Neurosurg"},{"key":"1434_CR143","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijrobp.2022.06.079","volume":"119","author":"JF Waxer","year":"2024","unstructured":"Waxer JF, Wong K, Modiri A, et al. Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: A PENTEC normal tissue outcomes comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119:417\u201330.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1434_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35275","author":"LC Verbruggen","year":"2024","unstructured":"Verbruggen LC, Kok JL, Kremer LCM, et al. Long-term risk and characteristics of cerebrovascular events after upper body radiotherapy among childhood cancer survivors in the DCCSS-LATER cohort. Int J Cancer. 2024. https:\/\/doi.org\/10.1002\/ijc.35275.","journal-title":"Int J Cancer"},{"key":"1434_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102484","author":"PY Zuo","year":"2014","unstructured":"Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: A meta-analysis. PLoS ONE. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0102484.","journal-title":"PLoS ONE"},{"key":"1434_CR146","unstructured":"Amrani M, El H.; 0, Debroucker; T, Roullet; E, Bousser M-G, Amarenco P (1998) Brain infarction following 5-fluorouracil and cisplatin therapy."},{"key":"1434_CR147","doi-asserted-by":"crossref","unstructured":"Serrano-Castro PJ, Guardado-Santerv\u00e1 P, Olivares-Romero J. Ischemic stroke following cisplatin and 5-Fluorouracil therapy. A Transcranial Doppler Study; 2000.","DOI":"10.1159\/000008197"},{"key":"1434_CR148","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1179\/joc.2010.22.2.134","volume":"22","author":"I Meattini","year":"2010","unstructured":"Meattini I, Scotti V, Pescini F, Livi L, Sulprizio S, Palumbo V, Sarti C, Bitt G. Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature. J Chemother. 2010;22:134\u20136.","journal-title":"J Chemother"},{"key":"1434_CR149","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00277-019-03860-2","volume":"99","author":"A Li","year":"2020","unstructured":"Li A, Wu Q, Warnick G, Li S, Libby EN, Garcia DA, Lyman GH. The incidence of thromboembolism for Lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma. Ann Hematol. 2020;99:121\u20136.","journal-title":"Ann Hematol"},{"key":"1434_CR150","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/annonc\/mdr148","volume":"23","author":"M Khasraw","year":"2012","unstructured":"Khasraw M, Holodny A, Goldlust SA, Deangelis LM. Intracranial hemorrhage in patients with cancer treated with bevacizumab: the memorial Sloan-Kettering experience. Ann Oncol. 2012;23:458\u201363.","journal-title":"Ann Oncol"},{"key":"1434_CR151","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00280-013-2155-4","volume":"71","author":"N Letarte","year":"2013","unstructured":"Letarte N, Bressler LR, Villano JL. Bevacizumab and central nervous system (CNS) hemorrhage. Cancer Chemother Pharmacol. 2013;71:1561\u20135.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1434_CR152","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.13162","volume":"168","author":"S Ranta","year":"2015","unstructured":"Ranta S, Tuckuviene R, M\u00e4kipernaa A, et al. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the nordic society of paediatric haematology and oncology. Br J Haematol. 2015;168:547\u201352.","journal-title":"Br J Haematol"},{"key":"1434_CR153","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/bjh.14048","volume":"174","author":"X Duarte","year":"2016","unstructured":"Duarte X, Esteves S, Neto AM, Pereira F. Incidence and risk factors for central nervous system thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: A single-centre cohort study. Br J Haematol. 2016;174:280\u201391.","journal-title":"Br J Haematol"},{"key":"1434_CR154","doi-asserted-by":"crossref","unstructured":"Malhotra P, Jain S, Kapoor G. (2018) Symptomatic cerebral sinovenous thrombosis associated with l-asparaginase in children with acute lymphoblastic leukemia: a single institution experience over 17 years.","DOI":"10.1097\/MPH.0000000000001127"},{"key":"1434_CR155","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24130","author":"M-A Couturier","year":"2015","unstructured":"Couturier M-A, Huguet F, Chevallier P, Suarez F, Thomas X, Escoffre-Barbe M, Cacheux V, Pignon J-M, Bonmati C, Sanhes L. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: the GRAALL experience. Am J Hematol. 2015. https:\/\/doi.org\/10.1002\/ajh.24130.","journal-title":"Am J Hematol"},{"key":"1434_CR156","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/jcpt.13598","volume":"47","author":"Q Yu","year":"2022","unstructured":"Yu Q, Xu Y, Yu E, Zheng Z. Risk of cardiovascular disease in breast cancer patients receiving aromatase inhibitors vs. tamoxifen: A systematic review and meta-analysis. J Clin Pharm Ther. 2022;47:575\u201387.","journal-title":"J Clin Pharm Ther"},{"key":"1434_CR157","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.breast.2021.07.004","volume":"59","author":"M Sund","year":"2021","unstructured":"Sund M, Garcia-Argibay M, Garmo H, Ahlgren J, Wennstig AK, Fredriksson I, Lindman H, Valachis A. Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study. Breast. 2021;59:157\u201364.","journal-title":"Breast"},{"key":"1434_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2221-5","author":"F Meng","year":"2016","unstructured":"Meng F, Zhu S, Zhao J, Vados L, Wang L, Zhao Y, Zhao D, Niu Y. Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review. BMC Cancer. 2016. https:\/\/doi.org\/10.1186\/s12885-016-2221-5.","journal-title":"BMC Cancer"},{"key":"1434_CR159","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000503906","volume":"104","author":"R Liu","year":"2020","unstructured":"Liu R, Zhou J, Xia S, Li T. Androgen deprivation therapy and the risk of stroke in patients with prostate cancer: an updated systematic review and Meta-Analysis. Urol Int. 2020;104:214\u201321.","journal-title":"Urol Int"},{"key":"1434_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.08.006","author":"Polter","year":"2024","unstructured":"Polter EJ, Prizment E, Walker A, Ryan RF, Wang Z, Blaes W, Lutsey AH. Cardiovascular disease with hormone therapy and ovarian suppression in premenopausal breast Cancer survivors. JACC CardioOncol. 2024. https:\/\/doi.org\/10.1016\/j.jaccao.2024.08.006.","journal-title":"JACC CardioOncol"},{"key":"1434_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70548","author":"S Elshafie","year":"2025","unstructured":"Elshafie S, Villa-Zapata L, Tackett RL, Zaghloul IY, Young HN. Cardiovascular and metabolic adverse events of endocrine therapies in women with breast cancer: A disproportionality analysis of reports in the FDA adverse event reporting system. Cancer Med. 2025. https:\/\/doi.org\/10.1002\/cam4.70548.","journal-title":"Cancer Med"},{"key":"1434_CR162","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.hlc.2023.10.008","volume":"33","author":"S Tan","year":"2024","unstructured":"Tan S, Spear E, Sane N, Chan J, Nelson AJ, Alamgeer M, Nerlekar N, Segelov E, Nicholls SJ. Atherosclerotic cardiovascular events in Cancer patients treated with immune checkpoint inhibitors: A retrospective cohort study. Heart Lung Circ. 2024;33:721\u20139.","journal-title":"Heart Lung Circ"},{"key":"1434_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16373","author":"Y Suzuki","year":"2023","unstructured":"Suzuki Y, Kaneko H, Tamura Y, et al. Cardiovascular events after the initiation of immune checkpoint inhibitors. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16373.","journal-title":"Heliyon"},{"key":"1434_CR164","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","volume":"10","author":"Y Je","year":"2009","unstructured":"Je Y, Schutz FAB, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors Sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncol. 2009;10:967\u201374.","journal-title":"Lancet Oncol"},{"key":"1434_CR165","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bjh.15690","volume":"184","author":"JR Brown","year":"2019","unstructured":"Brown JR, Moslehi J, Ewer MS, et al. Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: an integrated analysis. Br J Haematol. 2019;184:558\u201369.","journal-title":"Br J Haematol"},{"key":"1434_CR166","unstructured":"Seymour JF, Byrd JC, Ghia P et al. Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial."},{"key":"1434_CR167","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa2211582","volume":"388","author":"JR Brown","year":"2023","unstructured":"Brown JR, Eichhorst B, Hillmen P, et al. Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2023;388:319\u201332.","journal-title":"N Engl J Med"},{"key":"1434_CR168","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1200\/JCO.2009.27.2757","volume":"28","author":"TK Choueiri","year":"2010","unstructured":"Choueiri TK, Schutz FAB, Je Y, Rosenberg JE, Bellmunt J. Risk of arterial thromboembolic events with Sunitinib and sorafenib: A systematic review and meta-analysis of clinical trials. J Clin Oncol. 2010;28:2280\u20135.","journal-title":"J Clin Oncol"},{"key":"1434_CR169","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.critrevonc.2014.04.004","volume":"92","author":"WX Qi","year":"2014","unstructured":"Qi WX, Shen Z, Tang LN, Yao Y. Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis. Crit Rev Oncol Hematol. 2014;92:71\u201382.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1434_CR170","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/jamaoncol.2015.5932","volume":"2","author":"J Douxfils","year":"2016","unstructured":"Douxfils J, Haguet H, Mullier F, Chatelain C, Graux C, Dogn\u00e9 JM. Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival. JAMA Oncol. 2016;2:625\u201332.","journal-title":"JAMA Oncol"},{"key":"1434_CR171","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14740338.2017.1261824","volume":"16","author":"H Haguet","year":"2017","unstructured":"Haguet H, Douxfils J, Mullier F, Chatelain C, Graux C, Dogn\u00e9 JM. Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis. Expert Opin Drug Saf. 2017;16:5\u201312.","journal-title":"Expert Opin Drug Saf"},{"key":"1434_CR172","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMra2114482","volume":"388","author":"RG Geocadin","year":"2023","unstructured":"Geocadin RG. Posterior reversible encephalopathy syndrome. N Engl J Med. 2023;388:2171\u20138.","journal-title":"N Engl J Med"},{"key":"1434_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108265","author":"M Erritz\u00f8e-Jervild","year":"2025","unstructured":"Erritz\u00f8e-Jervild M, M\u00f8ller SN, Kruuse C, Sten\u00f8r C. Immune checkpoint inhibitor-related CNS vasculitis\u2013 A systematic review and report of 6 cases. J Stroke Cerebrovasc Dis. 2025. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108265.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1434_CR174","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2016.10.015","volume":"97","author":"C El-Fayech","year":"2017","unstructured":"El-Fayech C, Haddy N, Allodji RS, et al. Cerebrovascular diseases in childhood Cancer survivors: role of the radiation dose to Willis circle arteries. Int J Radiat Oncol Biol Phys. 2017;97:278\u201386.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1434_CR175","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.radonc.2019.09.025","volume":"142","author":"JY Lee","year":"2020","unstructured":"Lee JY, Kim YA, Kim HS, Back JH, Jung YH, Lee DH, Kim S. Radiotherapy can increase the risk of ischemic cerebrovascular disease in head and neck cancer patients: A Korean population-based cohort study. Radiother Oncol. 2020;142:85\u201391.","journal-title":"Radiother Oncol"},{"key":"1434_CR176","doi-asserted-by":"publisher","unstructured":"Liew E, Tan JX, Low CE et al. (2025) Stroke Risk in Head and Neck Cancer: A Meta-analysis of Reconstructed Individual Patient Survival Data. Otolaryngology - Head and Neck Surgery (United States). https:\/\/doi.org\/10.1002\/ohn.1249","DOI":"10.1002\/ohn.1249"},{"key":"1434_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35089","author":"DJ Carpenter","year":"2023","unstructured":"Carpenter DJ, Patel P, Niedzwiecki D, et al. Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer. Cancer. 2023. https:\/\/doi.org\/10.1002\/cncr.35089.","journal-title":"Cancer"},{"key":"1434_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13647-6","author":"JL Jiang","year":"2025","unstructured":"Jiang JL, Chang JTC, Huang BS, Chang TY, Sung PS, Wei YC, Lin CY, Yeh CH, Fan KH, Liu CH. Post-irradiation vertebral and carotid stenosis heightens stroke risk in head and neck cancer. BMC Cancer. 2025. https:\/\/doi.org\/10.1186\/s12885-025-13647-6.","journal-title":"BMC Cancer"},{"key":"1434_CR179","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.ijrobp.2024.03.044","volume":"119","author":"J Smith","year":"2024","unstructured":"Smith J, Margalit D, Golledge J, Nastasi D, Nohria A, McDowell L. Carotid artery stenosis and ischemic stroke in patients with head and neck Cancer treated with radiation therapy: A critical review. Int J Radiat Oncol Biol Phys. 2024;119:1437\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1434_CR180","doi-asserted-by":"crossref","unstructured":"van Dijk IWEM, van Os RM et al. (2016) Risk of symptomatic stroke after radiation therapy for childhood cancer: a long-term follow-up cohort analysis. In: Int J Radiat Oncol Biol Phys. Elsevier Inc., pp 597\u2013605.","DOI":"10.1016\/j.ijrobp.2016.03.049"},{"key":"1434_CR181","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pediatrneurol.2015.05.015","volume":"53","author":"J Passos","year":"2015","unstructured":"Passos J, Nzwalo H, Marques J, Azevedo A, Netto E, Nunes S, Salgado D. Late cerebrovascular complications after radiotherapy for childhood primary central nervous system tumors. Pediatr Neurol. 2015;53:211\u20135.","journal-title":"Pediatr Neurol"},{"key":"1434_CR182","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jns.2016.11.005","volume":"372","author":"J Passos","year":"2017","unstructured":"Passos J, Nzwalo H, Valente M, Marques J, Azevedo A, Netto E, Mota A, Borges A, Nunes S, Salgado D. Microbleeds and Cavernomas after radiotherapy for paediatric primary brain tumours. J Neurol Sci. 2017;372:413\u20136.","journal-title":"J Neurol Sci"},{"key":"1434_CR183","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-023-02055-8","author":"A Elkatatny","year":"2023","unstructured":"Elkatatny A, Ismail M, Ibrahim KMM, Aly MH, Fouda MA. The incidence of radiation-induced Moyamoya among pediatric brain tumor patients who received photon radiation versus those who received proton beam therapy: a systematic review. Neurosurg Rev. 2023. https:\/\/doi.org\/10.1007\/s10143-023-02055-8.","journal-title":"Neurosurg Rev"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01434-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01434-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:03:26Z","timestamp":1751364206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01434-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":183,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1434"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01434-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"25 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or ani\u00admal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"46"}}